Skip to content
Open access

Time to new-onset atrial fibrillation after transaortic valve implantation using 14-days ambulatory electrocardiographic monitoring

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

The importance of structured post-discharge rhythm surveillance to identify clinically actionable AF in this high-risk population of patients undergoing TAVI is underscore.

Abstract

Ambulatory long term ECG monitoring after transcatheter aortic valve implantation (TAVI) enables detection of arrhythmias that may otherwise remain underdiagnosed. While post-procedural conduction disturbances have been extensively studied, less attention has been directed toward the occurrence of atrial tachyarrhythmias after hospital discharge. The precise incidence and temporal distribution of new-onset atrial fibrillation (NOAF) during the in-hospital phase and after discharge remain insufficiently characterized. Adult patients undergoing TAVI at a Swiss tertiary centre were prospectively monitored using a 14-days ambulatory ECG patch applied prior to discharge. Patients were instructed to report any cardiac symptoms using the patch-reporting-system. NOAF was defined as AF episodes ≥ 30 seconds in patients without documented AF. A total of 307 patients underwent 14-day ambulatory ECG monitoring after TAVI (median age 82 years [78–86], 57% male). The median analyzable monitoring time was 13.3 days [11.5–13.8]. Atrial fibrillation was detected in 82 patients (27%), of whom 15 patients (5%) had NOAF. Among patients with NOAF, 12 (80%) were diagnosed exclusively through ambulatory patch monitoring after discharge, whereas 3 patients (20%) were diagnosed during in-hospital telemetry monitoring. In those diagnosed by ambulatory monitoring, the first AF episode occurred at a median of 6 days [2–10] after initiation of monitoring. Thirteen patients (87%) had paroxysmal AF and two (13%) had persistent AF. The median AF burden was 3% [1–12]. Only five patients (33%) reported symptoms temporally associated with AF episodes. The CHA₂DS₂-VA score was ≥2 in 14 patients (93%). Detection of NOAF led to a change from antiplatelet therapy to oral anticoagulation in four patients (27%) and initiation or adjustment of antiarrhythmic therapy in seven patients (47%). NOAF occurs in a small but clinically relevant proportion of patients undergoing TAVI, with the majority of cases remaining undetected during hospitalization. These findings underscore the importance of structured post-discharge rhythm surveillance to identify clinically actionable AF in this high-risk population.Graphical Abstract

Read PDF

Similar papers

Open access Oct 2026

Incidence and burden of new-onset atrial fibrillation after STEMI detected by 14-day ECG patch monitoring

Reported new-onset atrial fibrillation (NOAF) incidence following ST-segment elevation myocardial infarction (STEMI) varies widely, likely reflecting disease severity and differences in monitoring intensity. Robust data on post-STEMI AF burden is needed to guide therapeutic decisions, such as initiation of antico...

C. Moser, A. Bettelini, J. Bruegger et al. · 0 citations
Open access Oct 2026

Diagnostic yield of patient-triggered events during 14-days-electrocardiographic monitoring after transcatheter aortic valve implantation

Wearable ECG patches used after transcatheter aortic valve implantation (TAVI) enable continuous rhythm monitoring and allow patients to report symptoms via trigger buttons and diary entries. However, the correlation between triggered events and clinically relevant arrhythmias after TAVI remains uncertain....

A. Bettelini, C. Moser, F. Jordan et al. · 0 citations
Open access Oct 2026

Paired 14-day ECG monitoring reveals divergent arrhythmia dynamics before and after transcatheter aortic valve implantation

Therapeutic management after transcatheter aortic valve implantation (TAVI) requires precise rhythm risk stratification. While prior studies have described arrhythmias either before or after TAVI, intra-individual data quantifying qualitative and quantitative rhythm changes across the intervention remain limited....

C. Moser, A. Bettelini, J. Bruegger et al. · 0 citations
Nov 2026

Abstract 18093: Ambulatory Rhythm Monitoring After Transcatheter Aortic Valve Replacement: A Database Observational Study Using TriNetX Through May 2026

Background: Conduction abnormalities are common complications following transcatheter aortic valve replacement (TAVR). Real-world utilization of ambulatory rhythm monitoring after TAVR and its association with heart block detection needing pacemaker or ICD implantation remain poorly characterized. We evaluate ambula...

Tanisha Mishra, Lucas Chierici Pereira, Evan Isaacs et al. · 0 citations
Open access Oct 2026

Transcatheter aortic valve implantation and need for post-discharge pacemaker implantation in the modern era of fast discharge

Up to 20% of transcatheter aortic valve implantations (TAVIs) are followed by post-procedural conduction disturbances. As next-day discharge is becoming standard of care, predictors of permanent high-degree conduction disturbances requiring permanent pacemaker implantation (PPMI) are of increasing clinical releva...

A. D. Haue, A. A. Raja, D. Hoefsten et al. · 0 citations
Open access Oct 2026

Silent conduction disturbances after TAVI: insights from 12-lead holter monitoring

Conduction disturbances are common after transcatheter aortic valve implantation(TAVI) and may evolve dynamically in the post-procedural period. Brief or single ECG recordings may fail to capture transient or unstable conduction abnormalities. To prospectively evaluate conduction changes within 48 hours af...

S. Kesriklioglu, S. Tatar, Y. Alsancak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.